Accent Therapeutics secures J&J and BMS as new investors in $75M series C by Mark Eisenberg 23.01.2024 Pharmaceutical giants Bristol Myers Squibb and Johnson & Johnson invest in Accent Therapeutics, a leading RNA drug developer, contributing to ...